WELCOME TO THE CIMEDLIFE
Introducing a novel genre in chronic disease management




Our Company
Fast Growing New Generation Pharma Company
Composite Interceptive Med-Sciences Laboratories Private limited (CIMED) is the first pharma company developing the science of “interceptive medicine”, engineering therapeutics to stop, delay and reverse the inexorable progression of chronic diseases linked to lifestyle and aging. CIMED science focus is on safety over long-term use leveraging physiological mechanisms that normally promote healing by the body. We utilize a composite pharmacology- Polymolecular and soft targeting approach using the naturally derived molecular menu as an alternative to early medicalization by synthetic drugs. Our R&D focus also involves orphan areas of medicine where currently there is no standard of care treatments.
Our Focus

SCOPE OF SERVICES
PRODUCT DEVELOPMENT
RESEARCH AND DEVELOPMENT SERVICES
Our Values
To become global leaders in Interceptive Systems Medicine
01.
Innovation
Formulation Development and R&D services
02.
Teamwork
End to End Clinical research services
03.
Sustainable
Production standardization and scale-up Manufacturing services

Our Mission
To become a globally recognized enterprise creating knowledge base to aid discovery, research & development of composite pharmaceutics, products for interceptive healthcare, models of systems medicine to address unmet medical needs of chronic diseases.
To enable patients to return to normal life by pre-empting disease progression using a new genre of CIMED Interceptive therapeutics

WHY CIMED PRODUCTS ?





